---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-004999"
form_type: "8-K"
ticker: "NMRA"
cik: "0001885522"
company_name: "Neumora Therapeutics, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:57:26.289346+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Neumora Therapeutics presents at J.P. Morgan Healthcare Conference; no specific data disclosed in filing exhibit

## Summary
- Corporate presentation made available for J.P. Morgan Healthcare Conference on Jan 13, 2025.
- Presentation titled "Redefining Neuroscience Drug Development" but full content not provided.
- No financial or pipeline updates explicitly stated in the 8-K exhibit snippet.
- Confidence low due to incomplete exhibit text.

## SEC filing metadata
- accession: 0001193125-25-004999
- form_type: 8-K
- ticker: NMRA
- cik: 0001885522
- company_name: Neumora Therapeutics, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1885522/000119312525004999/0001193125-25-004999-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1885522/000119312525004999/d906757d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-004999
- JSON: https://secwatch.observer/filing/0001193125-25-004999.json
- Plain text: https://secwatch.observer/filing/0001193125-25-004999.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.